Philippa Musoke, MBChB, FAAP, PhD, MU-JHU Executive Director, is a paediatric infectious disease specialist by training and the former Head of Paediatrics and Child Health at Makerere University, College of Health Sciences. She has published widely on the prevention of mother to child HIV transmission (PMTCT) clinical trials and on paediatric antiretroviral treatment in resource-limited settings. Dr. Musoke has served as a technical advisor to WHO and is the Chair of the National PMTCT Technical Advisory Committee and Paediatric ART sub-committee for the Uganda Ministry of Health (MOH).
She has been a lead investigator on a number of NIH DAIDS PMTCT clinical trials; HIVNET012, PETRA, HPTN046, SWEN/HIVIGLOB, PROMISE and IMPAACT 2010; and also served as lead investigator for an operational PMTCT project using peer ‘sengas’ (or culturally influential ‘aunties’) to improve adherence to ART and retention in care for pregnant women on Option B+ in Kampala and a rural Mpigi District. After the HIVNET 012 trial results were released in 1999, Prof. Philippa Musoke and other investigators at MU-JHU assisted the MOH with the national scale-up of the single-dose nevirapine (NVP) regimen for PMTCT across Uganda and subsequent improvements in eMTCT interventions.
She has also been involved in multiple paediatric HIV/TB treatment trials including pharmacokinetic studies; P1060, P1070, P1092, P1093, P1115, Odyssey, ARROW, D3 and SHINE. She also received the EGPAF International Leadership Award where she conducted a study to determine the efficacy of the adult fixed-dose combination ART in children when paediatric formulations were not readily available. She is currently the Executive Director for MU-JHU Care Ltd and the principal investigator of the CDC funded Birth Defects Surveillance project.